D&A at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s D&A?
- Elanco Animal Health Inc. (ELAN) reported D&A of $172M in Q1 2026.
- How has Elanco Animal Health Inc.'s D&A changed year-over-year?
- Elanco Animal Health Inc.'s D&A increased by 6.8% year-over-year, from $161M to $172M.
- What is the long-term trend for Elanco Animal Health Inc.'s D&A?
- Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s D&A has grown at a -1.3% compound annual growth rate (CAGR), from $716M to $680M.
- What does D&A mean?
- The non-cash expense representing the wear and tear or expiration of assets.
- How do you interpret D&A?
- Higher values indicate significant capital investment, while lower values may suggest aging assets or a shift toward less capital-intensive operations.
- How does D&A compare across companies?
- Common in manufacturing and pharmaceutical industries; peers often have high levels due to heavy investment in production facilities.